Opendata, web and dolomites

QSEIF SIGNED

QSEIF: The new pathogen, DNA and immunological testing platform

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 QSEIF project word cloud

Explore the words cloud of the QSEIF project. It provides you a very rough idea of what is the project "QSEIF" about.

pcr    maturity    company    thanks    technological    pathogen    sales    market    animal    care    microbiology    internal    profit    automation    commercial    accumulated    innovation    point    processors    magnitude    infectious    certifications    2m    2024    qseif    net    install    investment    total    32m    dynamic    revenue    viability    first    lower    companies    specially    brc    22000    human    operability    environment    sme    food    period    perform    vaccination    immunological    diagnosis    orders    suit    88    feasibility    smes    regulatory    imicroq    diagnostic    cover    elisa    immunoassays    time    platform    ifs    immumological    hour    iso    disruptive    lauch    provides    24    tests    international    farm    2021    40    space    strategies    laboratories    involvement    detection    fulfil    validate    safety    instrument    customer    envision    financial    designed    disease    affordability    sectors    months    limit    reducing    717    biosafety    man    reference    performance    laboratory    breakthrough   

Project "QSEIF" data sheet

The following table provides information about the project.

Coordinator
IMICROQ SL 

Organization address
address: CALLE FERRO 6 NAVE 7 POLIGON INDUSTRIAL RIU CLAR
city: TARRAGONA
postcode: 43006
website: www.imicroq.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 1˙690˙250 €
 EC max contribution 1˙183˙175 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2021-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IMICROQ SL ES (TARRAGONA) coordinator 1˙183˙175.00

Map

 Project objective

iMiCROQ aims to bring to the market the first integrated platform for pathogen, immumological and PCR testing specially designed to cover the whole needs at farm level, internal control laboratories, food processors and point-of-care infectious disease testing. Thanks to its affordability, QSEIF will allow from SMEs to large companies to improve their biosafety and internal microbiology control to fulfil their requirements from ISO 22000, BRC or IFS certifications, while reducing the needs in laboratory space, the investment, the test cost and man-hour involvement thanks to higher automation. Another important breakthrough in the immunological sector is that QSEIF provides 1-2 orders of magnitude lower limit of detection, less time and better dynamic range than current reference test ELISA. We envision three important applications of this disruptive platform in the areas of: (1) Food Safety; (2) Vaccination Control; (3) Immunoassays for human and animal diagnosis. We will reach end-users from all these sectors according to different commercial strategies that have been tailored to suit each type of customer. The main objective of this project is to increase the technical maturity of the platform and to validate its performance and operability in operational environment with different end-users. After this 24 months project, we will lauch QSEIF to the market with the aim of becoming an international reference in the diagnostic market. The viability of the technological, regulatory, market and financial aspects of the QSEIF innovation project were assessed through a feasibility analysis carried out in SME Instrument Phase I. From the analysis, we expect to install 717 devices that would perform 5.2M tests in a five year period. By then, QSEIF platform will bring an accumulated Net Profit of 5,32M€ by 2024. It is expected that sales of QSEIF will represent 40% of the company’s total revenue in 2021, growing to 88% by 2024.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "QSEIF" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "QSEIF" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Savesight (2020)

Contact lens embedded sensor for ocular hypertension and glaucoma monitoring

Read More  

LOLAS (2019)

Precise and reliable autonomous landing for drones, helicopters and other rotorcraft

Read More  

ALR4000 (2019)

Automated LCD Recycling series 4000

Read More